|
May 1
|
TG Therapeutics (TGTX) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 1
|
TG Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results
|
|
Apr 28
|
TG Therapeutics to Host Conference Call on First Quarter 2023 Financial Results and Business Update
|
|
Apr 27
|
TG Therapeutics Announces Issuance of Permanent J-Code for BRIUMVI® (ublituximab-xiiy) from Centers for Medicare and Medicaid Services
|